Does a surgeon’s complication rate in a randomized controlled trial constitute a “significant new finding” that must be reported to patients during the consent process?
Physicians’ ethical obligations to disclose conflicts of interest to patients and to obtain their informed consent for treatment are particularly critical when proposed treatments are experimental.
An adolescent medicine fellow reviews the HEADSS assessment and provides a list of sample questions to ask adolescent patients when conducting a medical history.